The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases

Hepatology International

Volumn 4, Issue 4, 2010, Pages 659-672

  Soares, João Bruno ^a   Pimentel Nunes, Pedro ^a   Roncon Albuquerque Jr , Roberto ^a   Leite Moreira, Adelino ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Chronic liver diseases; Lipopolysaccharide; Toll like receptor 4

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; MYELOID DIFFERENTIATION FACTOR 88; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; AUTOIMMUNE DISEASE; CHRONIC LIVER DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; HYDROPHILICITY; INNATE IMMUNITY; LIGAND BINDING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 78649482865     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9219-x     Document Type: Review

References (84)

1. A Aderem RJ Ulevitch 2000 Toll-like receptors in the induction of the innate immune response Nature 406 782 787 1:STN:280:DC%2BD3cvjtVOhuw%3D%3D 10.1038/35021228 10963608
2. BA Beutler 2009 TLRs and innate immunity Blood 113 1399 1407 1:CAS:528:DC%2BD1MXitlCrt7g%3D 10.1182/blood-2008-07-019307 18757776
3. P Pimentel-Nunes JB Soares R Roncon-Albuquerque M Dinis-Ribeiro AF Leite-Moreira 2010 Toll-like receptors as therapeutic targets in gastrointestinal diseases Expert Opin Ther Targets 14 347 368 1:CAS:528:DC%2BC3cXjt1Kqt7w%3D 10.1517/14728221003642027 20146632
4. S Akira S Uematsu O Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 783 801 1:CAS:528:DC%2BD28Xit1Kltb8%3D 10.1016/j.cell.2006.02. 015 16497588 (Pubitemid 43261452)
5. S Akira K Takeda 2004 Toll-like receptor signalling Nat Rev Immunol 4 499 511 1:CAS:528:DC%2BD2cXlt1Cqur0%3D 10.1038/nri1391 15229469
6. HM Kim BS Park J Kim SE Kim J Lee SC Oh P Enkhbayar N Matsushima H Lee OJ Yoo J Lee 2007 Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran Cell 130 906 917 1:CAS:528:DC%2BD2sXhtV2ntLzN 10.1016/j.cell.2007.08.002 17803912 (Pubitemid 47332573)
7. CE Bryant DR Spring M Gangloff NJ Gay 2010 The molecular basis of the host response to lipopolysaccharide Nat Rev Microbiol 8 8 14 1:CAS:528:DC%2BD1MXhsVylsL%2FO 19946286
8. A Tsung R Sahai H Tanaka A Nakao MP Fink MT Lotze H Yang J Li KJ Tracey DA Geller TR Billiar 2005 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 1135 1143 1:CAS:528: DC%2BD2MXjtFWls7s%3D 10.1084/jem.20042614 15795240 (Pubitemid 40524681)
9. D Jiang J Liang J Fan S Yu S Chen Y Luo GD Prestwich MM Mascarenhas HG Garg DA Quinn RJ Homer DR Goldstein R Bucala PJ Lee R Medzhitov PW Noble 2005 Regulation of lung injury and repair by Toll-like receptors and hyaluronan Nat Med 11 1173 1179 1:CAS:528:DC%2BD2MXhtFOhsLvI 10.1038/nm1315 16244651 (Pubitemid 43093664)
10. H Shi MV Kokoeva K Inouye I Tzameli H Yin JS Flier 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 3015 3025 1:CAS:528:DC%2BD28XhtFyrsLfE 10.1172/JCI28898 17053832 (Pubitemid 44684486)
11. C Chen H Kono D Golenbock G Reed S Akira KL Rock 2007 Identification of a key pathway required for the sterile inflammatory response triggered by dying cells Nat Med 13 851 856 1:CAS:528:DC%2BD2sXnsFWmtrk%3D 10.1038/nm1603 17572686 (Pubitemid 47038190)
12. WE Naugler T Sakurai S Kim S Maeda K Kim AM Elsharkawy M Karin 2007 Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 121 124 1:CAS:528:DC%2BD2sXnt1SjtLc%3D 10.1126/science.1140485 17615358 (Pubitemid 47056470)
13. C Erridge 2010 Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 87 989 999 1:CAS:528:DC%2BC3cXnslCntbc%3D 10.1189/jlb.1209775 20179153
14. FY Liew D Xu EK Brint LAJ O'Neill 2005 Negative regulation of toll-like receptor-mediated immune responses Nat Rev Immunol 5 446 458 1:CAS:528:DC%2BD2MXks1GmsLo%3D 10.1038/nri1630 15928677 (Pubitemid 40835033)
15. J Davidson-Moncada FN Papavasiliou W Tam 2010 MicroRNAs of the immune system: roles in inflammation and cancer Ann N Y Acad Sci 1183 183 194 1:CAS:528:DC%2BC3cXisVehs7g%3D 10.1111/j.1749-6632.2009.05121.x 20146715
16. A De Creus M Abe AH Lau H Hackstein G Raimondi AW Thomson 2005 Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin J Immunol 174 2037 2045 15699133
17. KA Zarember PJ Godowski 2002 Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 554 561 1:CAS:528:DC%2BD38XksFWntg%3D%3D 11777946
18. GL Su RD Klein A Aminlari HY Zhang L Steinstraesser WH Alarcon DG Remick SC Wang 2000 Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4 Hepatology 31 932 936 1:CAS:528:DC%2BD3cXis1Cks78%3D 10.1053/he.2000.5634 10733550
19. E Seki H Tsutsui H Nakano N Tsuji K Hoshino O Adachi K Adachi S Futatsugi K Kuida O Takeuchi H Okamura J Fujimoto S Akira K Nakanishi 2001 Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta J Immunol 166 2651 2657 1:CAS:528:DC%2BD3MXht1Ghsro%3D 11160328
20. RF Schwabe E Seki DA Brenner 2006 Toll-like receptor signaling in the liver Gastroenterology 130 1886 1900 1:CAS:528:DC%2BD28Xls1Wit7s%3D 10.1053/j.gastro.2006.01.038 16697751 (Pubitemid 43668871)
21. E Seki S De Minicis CH Osterreicher J Kluwe Y Osawa DA Brenner RF Schwabe 2007 TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 1324 1332 1:CAS:528:DC%2BD2sXht1Kmtr3O 10.1038/nm1663 17952090 (Pubitemid 350073596)
22. K Machida H Tsukamoto H Mkrtchyan L Duan A Dynnyk HM Liu K Asahina S Govindarajan R Ray JJ Ou E Seki R Deshaies K Miyake MM Lai 2009 Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog Proc Natl Acad Sci USA 106 1548 1553 1:CAS:528:DC%2BD1MXhvVOrsLw%3D 10.1073/pnas.0807390106 19171902
23. Y Paik RF Schwabe R Bataller MP Russo C Jobin DA Brenner 2003 Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 37 1043 1055 1:CAS:528: DC%2BD3sXktVWns7Y%3D 10.1053/jhep.2003.50182 12717385 (Pubitemid 36538681)
24. H Fukui B Brauner JC Bode C Bode 1991 Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay J Hepatol 12 162 169 1:CAS:528:DyaK3MXktVaqu70%3D 10.1016/0168-8278(91)90933-3 2050995
25. A Parlesak C Schäfer T Schütz JC Bode C Bode 2000 Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease J Hepatol 32 742 747 1:CAS:528:DC%2BD3cXjslSktbk%3D 10.1016/S0168-8278(00)80242-1 10845660 (Pubitemid 30262733)
26. P Mathurin QG Deng A Keshavarzian S Choudhary EW Holmes H Tsukamoto 2000 Exacerbation of alcoholic liver injury by enteral endotoxin in rats Hepatology 32 1008 1017 1:CAS:528:DC%2BD3cXot1Wnsro%3D 10.1053/jhep.2000.19621 11050051
27. T Hauge J Persson D Danielsson 1997 Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers) Digestion 58 591 595 1:STN:280:DyaK1c%2FpvFCntA%3D%3D 10.1159/000201507 9438608
28. V Purohit JC Bode C Bode DA Brenner MA Choudhry F Hamilton YJ Kang A Keshavarzian R Rao RB Sartor C Swanson JR Turner 2008 Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium Alcohol 42 349 361 1:CAS:528: DC%2BD1cXosVOksL0%3D 10.1016/j.alcohol.2008.03.131 18504085
29. T Gustot A Lemmers C Moreno N Nagy E Quertinmont C Nicaise D Franchimont H Louis J Devière O Le Moine 2006 Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver Hepatology 43 989 1000 1:CAS:528:DC%2BD28XkvFGmt7Y%3D 10.1002/hep.21138 16628628 (Pubitemid 43724624)
30. GE Arteel 2003 Oxidants and antioxidants in alcohol-induced liver disease Gastroenterology 124 778 790 1:CAS:528:DC%2BD3sXisVKnt74%3D 10.1053/gast.2003.50087 12612915 (Pubitemid 36268494)
31. Y Adachi LE Moore BU Bradford W Gao RG Thurman 1995 Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 218 224 1:CAS:528:DyaK2MXjs12lurw%3D 10.1016/0016-5085(95)90027-6 7806045
32. AA Nanji U Khettry SM Sadrzadeh 1994 Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) Proc Soc Exp Biol Med 205 243 247 1:CAS:528:DyaK2cXisVWlt7s%3D 8171045
33. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001;34(1):101-108 (Pubitemid 32591488)
34. Y Adachi BU Bradford W Gao HK Bojes RG Thurman 1994 Inactivation of Kupffer cells prevents early alcohol-induced liver injury Hepatology 20 453 460 1:CAS:528:DyaK2cXmt1Citr8%3D 10.1002/hep.1840200227 8045507
35. I Hritz P Mandrekar A Velayudham D Catalano A Dolganiuc K Kodys E Kurt-Jones G Szabo 2008 The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 Hepatology 48 1224 1231 1:CAS:528:DC%2BD1cXht1Khu7%2FK 10.1002/hep.22470 18792393
36. G Bedogni L Miglioli F Masutti C Tiribelli G Marchesini S Bellentani 2005 Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 44 52 10.1002/hep.20734 15895401 (Pubitemid 40911310)
37. AJ Wigg IC Roberts-Thomson RB Dymock PJ McCarthy RH Grose AG Cummins 2001 The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis Gut 48 206 211 1:STN:280:DC%2BD3M7is1Wgtw%3D%3D 10.1136/gut.48.2.206 11156641 (Pubitemid 32141844)
38. I Bergheim S Weber M Vos S Krämer V Volynets S Kaserouni CJ McClain SC Bischoff 2008 Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin J Hepatol 48 983 992 1:CAS:528:DC%2BD1cXlvVSksLg%3D 10.1016/j.jhep.2008.01.035 18395289
39. CA Rivera P Adegboyega N van Rooijen A Tagalicud M Allman M Wallace 2007 Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J Hepatol 47 571 579 1:CAS:528:DC%2BD2sXpvF2msbg%3D 10.1016/j.jhep.2007.04.019 17644211 (Pubitemid 47331747)
40. P Brun I Castagliuolo V Di Leo A Buda M Pinzani G Palù D Martines 2007 Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis Am J Physiol Gastrointest Liver Physiol 292 G518 G525 1:CAS:528:DC%2BD2sXjt1Gltrs%3D 10.1152/ajpgi.00024.2006 17023554
41. PD Cani R Bibiloni C Knauf A Waget AM Neyrinck NM Delzenne R Burcelin 2008 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 1470 1481 1:CAS:528:DC%2BD1cXnsF2ju78%3D 10.2337/db07-1403 18305141
42. SQ Yang HZ Lin MD Lane M Clemens AM Diehl 1997 Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci USA 94 2557 2562 1:CAS:528:DyaK2sXhvF2ksLo%3D 10.1073/pnas.94.6.2557 9122234 (Pubitemid 27136914)
43. Z Li S Yang H Lin J Huang PA Watkins AB Moser C Desimone X Song AM Diehl 2003 Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 343 350 1:CAS:528: DC%2BD3sXhsFeltr4%3D 10.1053/jhep.2003.50048 12540784 (Pubitemid 36152533)
44. SF Solga AM Diehl 2003 Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics J Hepatol 38 681 687 1:CAS:528:DC%2BD3sXjtFerurk%3D 10.1016/S0168-8278(03)00097-7 12713883 (Pubitemid 36560657)
45. A Spruss G Kanuri S Wagnerberger S Haub SC Bischoff I Bergheim 2009 Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 50 1094 1104 1:CAS:528:DC%2BD1MXhtlWlu7nP 10.1002/hep.23122 19637282
46. PD Cani J Amar MA Iglesias M Poggi C Knauf D Bastelica AM Neyrinck F Fava KM Tuohy C Chabo A Waget E Delmée B Cousin T Sulpice B Chamontin J Ferrières JF Tanti GR Gibson L Casteilla NM Delzenne MC Alessi R Burcelin 2007 Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 1761 1772 1:CAS:528:DC%2BD2sXnvVWjurk%3D 10.2337/db06-1491 17456850 (Pubitemid 47025442)
47. MR Dasu S Devaraj S Park I Jialal 2010 Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects Diabetes Care 33 861 868 1:CAS:528:DC%2BC3cXlsleqtbY%3D 10.2337/dc09-1799 20067962
48. A Boonstra AM Woltman HLA Janssen 2008 Immunology of hepatitis B and hepatitis C virus infections Best Pract Res Clin Gastroenterol 22 1049 1061 1:CAS:528:DC%2BD1MXhtlOitLk%3D 10.1016/j.bpg.2008.11.015 19187866
49. A Dolganiuc O Norkina K Kodys D Catalano G Bakis C Marshall P Mandrekar G Szabo 2007 Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection Gastroenterology 133 1627 1636 1:CAS:528:DC%2BD2sXhsVGqtrvJ 10.1053/j.gastro.2007.08.003 17916356 (Pubitemid 350029734)
50. K Machida KTH Cheng VM Sung AM Levine S Foung MMC Lai 2006 Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6 J Virol 80 866 874 1:CAS:528: DC%2BD28XivVOqsg%3D%3D 10.1128/JVI.80.2.866-874.2006 16378988 (Pubitemid 43062898)
51. M Miyazaki T Kanto M Inoue I Itose H Miyatake M Sakakibara T Yakushijin N Kakita N Hiramatsu T Takehara A Kasahara N Hayashi 2008 Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I J Med Virol 80 980 988 1:CAS:528:DC%2BD1cXmtlOhsL4%3D 10.1002/jmv.21174 18428149 (Pubitemid 351657008)
52. T Abe Y Kaname I Hamamoto Y Tsuda X Wen S Taguwa K Moriishi O Takeuchi T Kawai T Kanto N Hayashi S Akira Y Matsuura 2007 Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines J Virol 81 8953 8966 1:CAS:528:DC%2BD2sXps1ams70%3D 10.1128/JVI.00649-07 17567694 (Pubitemid 47311439)
53. R Broering J Wu Z Meng P Hilgard M Lu M Trippler A Szczeponek G Gerken JF Schlaak 2008 Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication J Hepatol 48 914 922 1:CAS:528: DC%2BD1cXlvVSks7c%3D 10.1016/j.jhep.2008.01.028 18362039
54. H Huang ML Shiffman S Friedman R Venkatesh N Bzowej OT Abar CM Rowland JJ Catanese DU Leong JJ Sninsky TJ Layden TL Wright T White RC Cheung 2007 A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 46 297 306 1:CAS:528:DC%2BD2sXhtVSisb7P 10.1002/hep.21695 17461418 (Pubitemid 47344763)
55. J Guo J Loke F Zheng F Hong S Yea M Fukata M Tarocchi OT Abar H Huang JJ Sninsky SL Friedman 2009 Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses Hepatology 49 960 968 1:CAS:528:DC%2BD1MXjvFOmsLk%3D 10.1002/hep.22697 19085953
56. AS Sozinov 2002 Systemic endotoxemia during chronic viral hepatitis Bull Exp Biol Med 133 153 155 1:CAS:528:DC%2BD38XmsVOltLc%3D 10.1023/A:1015546821875 12428283
57. Z Chen Y Cheng Y Xu J Liao X Zhang Y Hu Q Zhang J Wang Z Zhang F Shen Z Yuan 2008 Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients Clin Immunol 128 400 408 1:CAS:528:DC%2BD1cXhtVShtr3K 10.1016/j.clim.2008.04.006 18565796
58. M Isogawa MD Robek Y Furuichi FV Chisari 2005 Toll-like receptor signaling inhibits hepatitis B virus replication in vivo J Virol 79 7269 7272 1:CAS:528:DC%2BD2MXksFKgtr0%3D 10.1128/JVI.79.11.7269-7272.2005 15890966 (Pubitemid 40677357)
59. J Wu M Lu Z Meng M Trippler R Broering A Szczeponek F Krux U Dittmer M Roggendorf G Gerken JF Schlaak 2007 Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice Hepatology 46 1769 1778 1:CAS:528:DC%2BD2sXhsVGiur%2FN 10.1002/hep.21897 17929296
60. K Sasatomi K Noguchi S Sakisaka M Sata K Tanikawa 1998 Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis J Hepatol 29 409 416 1:CAS:528:DyaK1cXmvVWnsrg%3D 10.1016/S0168-8278(98)80058-5 9764987 (Pubitemid 28396657)
61. E Ballot O Bandin O Chazouilleres C Johanet R Poupon 2004 Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases J Autoimmun 22 153 158 1:CAS:528:DC%2BD2cXhsV2gurk%3D 10.1016/j.jaut.2003.11.002 14987744 (Pubitemid 38252972)
62. A Wang K Migita M Ito Y Takii M Daikoku T Yokoyama A Komori M Nakamura H Yatsuhashi H Ishibashi 2005 Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis J Autoimmun 25 85 91 10.1016/j.jaut.2005.05.003 16006099 (Pubitemid 41008670)
63. TK Mao Z Lian C Selmi Y Ichiki P Ashwood AA Ansari RL Coppel S Shimoda H Ishibashi ME Gershwin 2005 Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis Hepatology 42 802 808 1:CAS:528:DC%2BD2MXhtFGlsbjL 10.1002/hep.20859 16175622 (Pubitemid 41401117)
64. A Karrar U Broomé T Södergren M Jaksch A Bergquist M Björnstedt S Sumitran-Holgersson 2007 Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis Gastroenterology 132 1504 1514 1:CAS:528:DC%2BD2sXlslKru7Y%3D 10.1053/j.gastro.2007.01.039 17408653 (Pubitemid 46627575)
65. R Bataller DA Brenner 2005 Liver fibrosis J Clin Invest 115 209 218 1:CAS:528:DC%2BD2MXhtFyjs70%3D 15690074
66. NC Henderson JP Iredale 2007 Liver fibrosis: cellular mechanisms of progression and resolution Clin Sci 112 265 280 1:CAS:528:DC%2BD2sXhtFWhu7o%3D 10.1042/CS20060242 17261089 (Pubitemid 46392114)
67. CC Chan SJ Hwang FY Lee SS Wang FY Chang CP Li CJ Chu RH Lu SD Lee 1997 Prognostic value of plasma endotoxin levels in patients with cirrhosis Scand J Gastroenterol 32 942 946 1:STN:280:DyaK2svksVCnug%3D%3D 10.3109/ 00365529709011206 9299675
68. R Wiest G Garcia-Tsao 2005 Bacterial translocation (BT) in cirrhosis Hepatology 41 422 433 1:CAS:528:DC%2BD2MXisFCku7g%3D 10.1002/hep.20632 15723320 (Pubitemid 40289486)
69. T Manigold U Böcker C Hanck J Gundt P Traber C Antoni S Rossol 2003 Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis Eur J Gastroenterol Hepatol 15 275 282 1:CAS:528:DC%2BD3sXhsF2isL8%3D 10.1097/00042737-200303000-00011 12610323 (Pubitemid 36337848)
70. SM Riordan N Skinner A Nagree H McCallum CJ McIver J Kurtovic JA Hamilton S Bengmark R Williams K Visvanathan 2003 Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 1154 1164 1:CAS:528:DC%2BD3sXktVWnsLc%3D 10.1053/jhep.2003.50180 12717397 (Pubitemid 36538693)
71. KA Tazi J Quioc V Saada A Bezeaud D Lebrec R Moreau 2006 Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M J Hepatol 45 280 289 1:CAS:528:DC%2BD28Xmslylu78%3D 10.1016/j.jhep.2006.02.013 16635535 (Pubitemid 44026567)
72. J Lata I Novotný V Príbramská J Jurá nková P Fric R Kroupa O Stibůrek 2007 The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study Eur J Gastroenterol Hepatol 19 1111 1113 10.1097/MEG.0b013e3282efa40e 17998837 (Pubitemid 350125383)
73. J Fernández M Navasa R Planas S Montoliu D Monfort G Soriano C Vila A Pardo E Quintero V Vargas J Such P Ginès V Arroyo 2007 Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 818 824 10.1053/j.gastro.2007.06.065 17854593 (Pubitemid 47374144)
74. TD Luckey JA Reyniers P Gyorgy M Forbes 1954 Germfree animals and liver necrosis Ann N Y Acad Sci 57 932 935 1:STN:280:DyaG2c7gtFCrtQ%3D%3D 10.1111/j.1749-6632.1954.tb36472.x 13181325
75. AM Rutenburg E Sonnenblick I Koven HA Aprahamian L Reiner J Fine 1957 The role of intestinal bacteria in the development of dietary cirrhosis in rats J Exp Med 106 1 14 1:CAS:528:DyaG2sXpt1aitw%3D%3D 10.1084/jem.106.1.1 13439110
76. A Velayudham A Dolganiuc M Ellis J Petrasek K Kodys P Mandrekar G Szabo 2009 VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice Hepatology 49 989 997 1:CAS:528:DC%2BD1MXjvFOmsb0%3D 10.1002/hep.22711 19115316
77. F Isayama IN Hines M Kremer RJ Milton CL Byrd AW Perry SE McKim C Parsons RA Rippe MD Wheeler 2006 LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice Am J Physiol Gastrointest Liver Physiol 290 G1318 G1328 1:CAS:528:DC%2BD28XlvVeisbY%3D 10.1152/ajpgi.00405.2005 16439470 (Pubitemid 43788315)
78. Y Li M Chang O Abar V Garcia C Rowland J Catanese D Ross S Broder M Shiffman R Cheung T Wright SL Friedman J Sninsky 2009 Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection J Hepatol 51 750 757 1:CAS:528:DC%2BD1MXhtFagt77K 10.1016/j.jhep.2009.04.027 19586676
79. M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 749 759 1:CAS:528:DC%2BD2MXhtVGrurvL 10.1038/nri1703 16175180 (Pubitemid 41400849)
80. M Karin 2006 Nuclear factor-kappaB in cancer development and progression Nature 441 431 436 1:CAS:528:DC%2BD28XkvVyrsrw%3D 10.1038/nature04870 16724054 (Pubitemid 44050137)
81. FX Bosch J Ribes M Díaz R Cléries 2004 Primary liver cancer: worldwide incidence and trends Gastroenterology 127 S5 S16 10.1053/j.gastro.2004.09.011 15508102 (Pubitemid 39423365)
82. S Maeda H Kamata J Luo H Leffert M Karin 2005 IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis Cell 121 977 990 1:CAS:528:DC%2BD2MXmtF2nsbo%3D 10.1016/j.cell.2005.04.014 15989949 (Pubitemid 40884391)
83. J Lee I Chu A Mikaelyan DF Calvisi J Heo JK Reddy SS Thorgeirsson 2004 Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 1306 1311 1:CAS:528:DC%2BD2cXhtVWitLnO 10.1038/ng1481 15565109 (Pubitemid 39577940)
84. C Brechot B Nalpas MA Feitelson 1996 Interactions between alcohol and hepatitis viruses in the liver Clin Lab Med 16 273 287 1:STN:280: DyaK28zosVWktw%3D%3D 8792072 (Pubitemid 26185267)